

| Supplement | Recommended Stock Concentration | Final Concentration to be used on cells | Diluent | |
| Ascorbic Acid | 200 mM | 0.2 mM | Water for Cell Culture | |
| hBDNF | 100 µg/mL | 20 ng/mL | 0.1% BSA in Water for Cell Culture | |
| CHIR99021 | 10 mM | 3 µM | DMSO | |
| DAPT | 50 mM | 10 µM | DMSO | |
| dibutyryl cAMP | 100 mM | 0.5 mM | Water for Cell Culture | |
| hFGF8a | 100 µg/mL | 100 ng/mL | 0.1% BSA in Water for Cell Culture | |
| hGDNF | 100 µg/mL | 20 ng/mL | 0.1% BSA in Water for Cell Culture | |
| LDN193189 | 1 mM | 100 nM | DMSO | |
| Purmorphamine | 20 mM | 1 µM | DMSO | |
| SAG | 1 mM | 100 nM | DMSO | |
| SB431542 | 10mM | 10µM | DMSO | |
| TGF-β3 | 25µg/mL | 1ng/mL | 10mM Citric Acid & 0.1% BSA in Water for Cell Culture (1:3)* |
| Day | Media Change | Media Type | Media feed volume per well | |
| 0-12 | Daily | Differs (See 'Media Composition') | 2 mL | |
| 13-19 | Daily | Maturation Medium | 2 mL | |
| 20 | Passage | Maturation Medium | - | |
| 21-22 | Daily | Maturation Medium | 1 mL | |
| 23-33 | Every other day | Maturation Medium | 2 mL | |
| 34-52 | Every 2 (*or 3) days | Maturation Medium | 2mL (*or 3mL) |
| KOSR (use within 1 week) | 100mL | 1mL | [Final] | |
| Knockout DMEM | 81.98 mL | 819.8 µL | - | |
| Knockout Serum Replacement (KSR) | 15 mL | 150 µL | 15% | |
| Glutamax (100X) | 1 mL | 10 µL | 1X | |
| MEM Non Essential Amino Acids (NEAA) (100X) | 1 mL | 10 µL | 1mM | |
| 2-mercaptoethanol (50mM) | 20 µL | 0.2 µL | 0.01mM | |
| Penicillin-Streptomycin (10,000 U/mL) | 1 mL | 10 µL | 100 U/mL |
| NNB (Use within 3 days) | 100mL | 1mL | [Final] | |
| Neurobasal medium | 96.5 mL | 965 µL | - | |
| N2 (100X) | 0.5 mL | 5 µL | 0.5X | |
| B27 (50X) | 1 mL | 10 µL | 0.5X | |
| Glutamax (100X) | 1 mL | 10 µL | 1X | |
| Penicillin-Streptomycin (10,000 U/mL) | 1 mL | 10 µL | 100 U/mL |
| NB/B27 (Use within 3 days) | 100mL | 1mL | [Final] | |
| Neurobasal medium | 96 mL | 0.96 mL | - | |
| B27 (50X) | 2 mL | 20 µL | 1X | |
| Glutamax (100X) | 1 mL | 10 µL | 1X | |
| Penicillin-Streptomycin (10,000 U/mL) | 1 mL | 10 µL | 100 U/mL |
| Day 0 | Neural Induction Medium-1 | 28 mL | 1mL | [Final] | |
| (Sat) | KOSR | 28mL | 1 mL | 100% | |
| LDN193189 (stock 1 mM) | 2.8 µL | 0.1 µL | 100 nM | ||
| SB431542 (stock 10 mM) | 28 µL | 1 µL | 10 µM | ||
| Day 1-2 | Neural Induction Medium-2 | 28 mL | 1 mL | ||
| (Sun/Mon) | KOSR | 28mL | 1 mL | 100% | |
| LDN193189 (stock 1 mM) | 2.8 µL | 0.1 µL | 100 nM | ||
| SB431542 (stock 1 0mM) | 28 µL | 1 µL | 10 µM | ||
| SAG (stock 1 mM) | 2.8 µL | 0.1 µL | 100 nM | ||
| Purmorphamine (stock 20 mM) | 2.8 µL | 0.1 µL | 2 µM | ||
| FGF8a (stock 100 µg/mL) | 28 µL | 1 µL | 100ng/mL | ||
| Day 3-4 | Neural Induction Medium-3 | 28 mL | 1 mL | [Final] | |
| (Tue/Wed) | KOSR | 28mL | 1 mL | 100% | |
| LDN193189 (stock 1 mM) | 2.8 µL | 0.1 µL | 100 nM | ||
| SB431542 (stock 10 mM) | 28 µL | 1 µL | 10 µM | ||
| SAG (stock 1 mM) | 2.8 µL | 0.1 µL | 100 nM | ||
| Purmorphamine (stock 20 mM) | 2.8 µL | 0.1 µL | 2 µM | ||
| FGF8a (stock 100 µg/mL) | 28 µL | 1 µL | 100ng/mL | ||
| CHIR99021 (stock 10 mM) | 8.4 µL | 0.3 uL | 3 µM | ||
| Day 5-6 | Neural Induction Medium-4 | 28 mL | 1 mL | [Final] | |
| (Thu/Fri) | KOSR | 21 mL | 0.75 mL | 75% | |
| NNB | 7 mL | 0.25 mL | 25% | ||
| LDN193189 (stock 1 mM) | 2.8 µL | 0.1 µL | 100 nM | ||
| SAG (stock 1mM) | 2.8 µL | 0.1 µL | 100 nM | ||
| Purmorphamine (stock 20mM) | 2.8 µL | 0.1 µL | 2 µM | ||
| FGF8a (stock 100 µg/mL) | 28 µL | 1 µL | 100ng/mL | ||
| CHIR99021 (stock 10 mM) | 8.4 µL | 0.3 uL | 3 µM | ||
| Day 7-8 | Neural Induction Medium-5 | 28 mL | 1 mL | [Final] | |
| (Sat/Sun) | KOSR | 14 mL | 0.5 mL | 50% | |
| NNB | 14 mL | 0.5 mL | 50% | ||
| LDN193189 (stock 1 mM) | 2.8 µL | 0.1 µL | 100 nM | ||
| CHIR99021 (stock 10 mM) | 8.4 µL | 0.3 uL | 3 µM | ||
| Day 9-10 | Neural Induction Medium-6 | 28 mL | 1 mL | [Final] | |
| (Mon/Tue) | KOSR | 7 mL | 0.25 mL | 25% | |
| NNB | 21 mL | 0.75 mL | 75% | ||
| LDN193189 (stock 1 mM) | 2.8 µL | 0.1 µL | 100 nM | ||
| CHIR99021 (stock 10 mM) | 8.4 µL | 0.3 uL | 3 µM | ||
| Day 11-12 | Neural Induction Medium-7 | 28 mL | 1 mL | [Final] | |
| (Wed/Thu) | Maturation Medium | 28 mL | 1 mL | 100% | |
| CHIR99021 (stock 10 mM) | 8.4 µL | 0.3 µL | 3 µM |
| Maturation Medium (Use within 1 day) | 28mL | 1mL | [Final] | |
| NB/B27 | ||||
| Neurobasal medium | 26.88 mL | 960 µL | - | |
| B27 (50X) | 560 µL | 20 µL | 1X | |
| Glutamax (100X) | 280 µL | 10 µL | 1X | |
| Penicillin-Streptomycin (10,000 U/mL) | 280 µL | 10 µL | 100 U/mL | |
| Supplements | ||||
| BDNF (stock 100 µg/mL) | 5.6 µL | 0.2 µL | 20 ng/mL | |
| DAPT (stock 50 mM) | 5.6 µL | 0.2 µL | 10 uM | |
| GDNF (stock 100 µg/mL) | 5.6 µL | 0.2 µL | 20 ng/mL | |
| TGFB3 (stock 25 µg/mL) | 1.12 µL | 0.04 µL | 1 ng/mL | |
| Dibutyryl cAMP (stock 100mM) | 140 µL | 5 µL | 0.5 mM | |
| Ascorbic acid (stock 200mM) | 28 µL | 1 µL | 0.2 mM |